Structural transformation of the amyloidogenic core region of TDP-43 protein initiates its aggregation and cytoplasmic inclusion

J Biol Chem. 2013 Jul 5;288(27):19614-24. doi: 10.1074/jbc.M113.463828. Epub 2013 May 20.

Abstract

TDP-43 (TAR DNA-binding protein of 43 kDa) is a major deposited protein in amyotrophic lateral sclerosis and frontotemporal dementia with ubiquitin. A great number of genetic mutations identified in the flexible C-terminal region are associated with disease pathologies. We investigated the molecular determinants of TDP-43 aggregation and its underlying mechanisms. We identified a hydrophobic patch (residues 318-343) as the amyloidogenic core essential for TDP-43 aggregation. Biophysical studies demonstrated that the homologous peptide formed a helix-turn-helix structure in solution, whereas it underwent structural transformation from an α-helix to a β-sheet during aggregation. Mutation or deletion of this core region significantly reduced the aggregation and cytoplasmic inclusions of full-length TDP-43 (or TDP-35 fragment) in cells. Thus, structural transformation of the amyloidogenic core initiates the aggregation and cytoplasmic inclusion formation of TDP-43. This particular core region provides a potential therapeutic target to design small-molecule compounds for mitigating TDP-43 proteinopathies.

Keywords: Aggregation; Amyloid; Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease); Circular Dichroism (CD); Fluorescence; Hydrophobic Patch; Inclusion Formation; NMR; Structural Transformation; TDP-43.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid / genetics
  • Amyloid / metabolism*
  • Animals
  • Caenorhabditis elegans
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Drug Design
  • HeLa Cells
  • Helix-Turn-Helix Motifs
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Inclusion Bodies / genetics
  • Inclusion Bodies / metabolism*
  • Inclusion Bodies / pathology
  • Protein Structure, Tertiary
  • TDP-43 Proteinopathies / drug therapy
  • TDP-43 Proteinopathies / genetics
  • TDP-43 Proteinopathies / metabolism
  • TDP-43 Proteinopathies / pathology

Substances

  • Amyloid
  • DNA-Binding Proteins